BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35948170)

  • 1. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
    Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
    Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
    J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
    Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 May; 199():115022. PubMed ID: 35358477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation.
    Pyun DH; Kim TJ; Park SY; Lee HJ; Abd El-Aty AM; Jeong JH; Jung TW
    Mol Cell Endocrinol; 2021 Dec; 538():111464. PubMed ID: 34601002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR-mediated inhibition of autophagy under hyperlipidemic conditions.
    Oh H; Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Kwon CH; Jeong JH; Jung TW
    J Cell Physiol; 2022 Nov; 237(11):4226-4237. PubMed ID: 36087347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stachydrine alleviates lipid-induced skeletal muscle insulin resistance via AMPK/HO-1-mediated suppression of inflammation and endoplasmic reticulum stress.
    Jung TW; Kim H; Park SY; Cho W; Oh H; Lee HJ; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH
    J Endocrinol Invest; 2022 Nov; 45(11):2181-2191. PubMed ID: 35834165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress.
    Choi SW; Cho W; Oh H; Abd El-Aty AM; Hong SA; Hong M; Jeong JH; Jung TW
    Biochem Pharmacol; 2023 Nov; 217():115815. PubMed ID: 37741512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
    Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
    J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.
    Jung TW; Hong HC; Hwang HJ; Yoo HJ; Baik SH; Choi KM
    Mol Cell Endocrinol; 2015 Dec; 417():131-40. PubMed ID: 26419929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis.
    Cho W; Oh H; Abd El-Aty AM; Özten Ö; Jeong JH; Jung TW
    Biochem Biophys Res Commun; 2024 Apr; 703():149671. PubMed ID: 38367515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
    Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
    J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abietic acid alleviates endoplasmic reticulum stress and lipid accumulation in human primary hepatocytes through the AMPK/ORP150 signaling.
    Jung TW; Jeong JC; Park SY; Cho W; Oh H; Lee HJ; Hacimuftuoglu A; Abd El-Aty AM; Bang JS; Jeong JH
    Biochem Biophys Res Commun; 2022 Jun; 608():142-148. PubMed ID: 35398611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway.
    Kwon C; Sun JL; Jeong JH; Jung TW
    Biochem Biophys Res Commun; 2020 May; 526(2):539-545. PubMed ID: 32245619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokine gremlin-1 promotes hepatic steatosis via upregulation of ER stress by suppressing autophagy-mediated signaling.
    Choi SW; Oh H; Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
    J Cell Physiol; 2023 May; 238(5):966-975. PubMed ID: 36890751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARδ-dependent pathway in mice.
    Jung TW; Hwang HJ; Hong HC; Yoo HJ; Baik SH; Choi KM
    Diabetologia; 2015 Sep; 58(9):2096-105. PubMed ID: 26105792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice.
    Jung TW; Lee SH; Kim HC; Bang JS; Abd El-Aty AM; Hacımüftüoğlu A; Shin YK; Jeong JH
    Exp Mol Med; 2018 Sep; 50(9):1-11. PubMed ID: 30213948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
    Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
    J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway.
    Yang Y; Qiu W; Xiao J; Sun J; Ren X; Jiang L
    J Transl Med; 2024 Mar; 22(1):309. PubMed ID: 38532480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.